Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, Worcester MA, New York NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, New York NY, Philadelphia PA, Charlotte NC,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase 1, Phase 2, Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
for
Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP),
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 18 - 70+
Code: NCT07218016
Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Baltimore MD, Richmond VA, Aventura FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03606967
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
for
Bleeding Disorders, Iron, Platelet, Bleeding
Location: Pittsburgh PA
Sponsor: Nicoletta C Machin
Sex: All
Age: 15+
Code: NCT07083583
Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Phase 4, Recruiting
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
for
Proliferative Diabetic Retinopathy (PDR)
Location: Boston MA, Baltimore MD, Rochester NY, Chapel Hill NC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT06790784
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)